Works matching IS 11732563 AND DT 2023 AND VI 43 AND IP 12

Results: 8

Monotherapy Versus Combination Therapy in the Treatment of Painful Diabetic Neuropathy: A Systematic Review and Meta-analysis.
Published in:
Clinical Drug Investigation, 2023, v. 43, n. 12, p. 905, doi. 10.1007/s40261-023-01318-y
By:
- Medeiros Dantas, Julyana;
- de Jesus Oliveira, Mariana;
- Silva, Luciana Alves Oliveira;
- Batista, Sávio;
- Dagostin, Caroline Serafim;
- Schachter, Daniel Campinho
Publication type:
Article
Glucagon-Like Peptide-1 Receptor Agonist and Risk of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials.
Published in:
Clinical Drug Investigation, 2023, v. 43, n. 12, p. 915, doi. 10.1007/s40261-023-01319-x
By:
- Jiao, Xiaojuan;
- Peng, Ping;
- Zhang, Qin;
- Shen, Yunfeng
Publication type:
Article
Correction: Pharmacokinetics and Safety of Erenumab after a Single Subcutaneous Injection Dose in Healthy Chinese Subjects.
Published in:
2023
By:
- Shen, Qi;
- Jin, Ying;
- Di, Xiangjie;
- Hu, Chao;
- Liu, Runhan;
- Wang, Ying;
- Qi, Xiaohui;
- Wang, Yongsheng;
- Wang, Zhenlei
Publication type:
Correction Notice
Clinical and Laboratory Factors Related to Seizure and Serotonin Toxicity in Tramadol Intoxication: An Egyptian Study.
Published in:
Clinical Drug Investigation, 2023, v. 43, n. 12, p. 963, doi. 10.1007/s40261-023-01326-y
By:
- Ali, Ahmed Amin;
- Abdeshafy, Mahmoud Mohamed;
- Abdelkawy, Khaled;
- Elsabaa, Ramy M.;
- Elbarbry, Fawzy
Publication type:
Article
Is Alpelisib Plus Fulvestrant Cost-Effective for Treating PIK3CA-Mutation, HR+/HER2− Advanced Breast Cancer in the USA?
Published in:
Clinical Drug Investigation, 2023, v. 43, n. 12, p. 939, doi. 10.1007/s40261-023-01325-z
By:
- Wu, Wenhua;
- Lin, Huiting;
- Cai, Jiaqin;
- Sun, Hong;
- Liu, Jia;
- Hu, Congting;
- Wei, Xiaoxia
Publication type:
Article
Tauro-Urso-Deoxycholic Acid Trials in Amyotrophic Lateral Sclerosis: What is Achieved and What to Expect.
Published in:
Clinical Drug Investigation, 2023, v. 43, n. 12, p. 893, doi. 10.1007/s40261-023-01324-0
By:
- Lo Giudice, Maria;
- Cocco, Antoniangela;
- Reggiardo, Giorgio;
- Lalli, Stefania;
- Albanese, Alberto
Publication type:
Article
Safety Concerns with Nusinersen, Risdiplam, and Onasemnogene Abeparvovec in Spinal Muscular Atrophy: A Real-World Pharmacovigilance Study.
Published in:
Clinical Drug Investigation, 2023, v. 43, n. 12, p. 949, doi. 10.1007/s40261-023-01320-4
By:
- Zhuang, Wei;
- Lu, Mei;
- Wu, Ye;
- Chen, Zhehui;
- Wang, Minying;
- Wang, Xudong;
- Guan, Shaoxing;
- Lin, Wanlong
Publication type:
Article
Efficacy and Safety of Switching from Sitagliptin to Ipragliflozin in Obese Japanese Patients with Type 2 Diabetes Mellitus: A Single-Arm Multicenter Interventional Study.
Published in:
Clinical Drug Investigation, 2023, v. 43, n. 12, p. 927, doi. 10.1007/s40261-023-01317-z
By:
- Watanabe, Kentaro;
- Yamaguchi, Susumu;
- Kosakai, Yoshinori;
- Ioji, Tetsuya;
- Ishihara, Hisamitsu
Publication type:
Article